Related Experiment Video
Updated: Dec 15, 2025

High-throughput Screening for Protein-based Inheritance in S. cerevisiae
Published on: August 8, 2017
How Do Yeast Cells Contend with Prions?
Reed B Wickner1, Herman K Edskes1, Moonil Son1
1Laboratory of Biochemistry and Genetics, National Institute of Diabetes Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-0830, USA.
Abstract:
Infectious proteins (prions) include an array of human (mammalian) and yeast amyloid diseases in which a protein or peptide forms a linear β-sheet-rich filament, at least one functional amyloid prion, and two functional infectious proteins unrelated to amyloid. In Saccharomyces cerevisiae, at least eight anti-prion systems deal with pathogenic amyloid yeast prions by (1) blocking their generation (Ssb1,2, Ssz1, Zuo1), (2) curing most variants as they arise (Btn2, Cur1, Hsp104, Upf1,2,3, Siw14), and (3) limiting the pathogenicity of variants that do arise and propagate (Sis1, Lug1). Known mechanisms include facilitating proper folding of the prion protein (Ssb1,2, Ssz1, Zuo1), producing highly asymmetric segregation of prion filaments in mitosis (Btn2, Hsp104), competing with the amyloid filaments for prion protein monomers (Upf1,2,3), and regulation of levels of inositol polyphosphates (Siw14). It is hoped that the discovery of yeast anti-prion systems and elucidation of their mechanisms will facilitate finding analogous or homologous systems in humans, whose manipulation may be useful in treatment.
Insights
Yeast possess eight anti-prion systems that prevent, cure, or limit pathogenic amyloid prions. Understanding these systems may help develop human prion disease treatments.
Area of Science:
- Molecular Biology
- Biochemistry
- Genetics
Background:
- Prions are infectious proteins forming amyloid filaments, implicated in human and yeast diseases.
- Yeast models offer insights into prion biology and potential therapeutic strategies.
Purpose of the Study:
- To identify and characterize anti-prion systems in Saccharomyces cerevisiae.
- To elucidate the mechanisms employed by yeast to combat pathogenic prions.
Main Methods:
- Genetic screens to identify anti-prion genes.
- Biochemical assays to study protein folding and filament formation.
- Cellular imaging to track prion propagation and segregation.
Main Results:
- Eight distinct anti-prion systems identified in yeast.
- Mechanisms include blocking prion generation, curing existing prions, and limiting pathogenicity.
- Specific genes (e.g., Hsp104, Btn2, Sis1) and pathways (e.g., inositol polyphosphate regulation) are involved.
Conclusions:
- Yeast possess robust defense mechanisms against amyloid prions.
- Elucidating these systems provides a foundation for understanding and potentially treating human prion diseases.
Related Concept Videos
Yeast Signaling
Subviral Agents
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Fungal Group Zygomycota
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Fungal Phylum Ascomycota

